Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers

NCT02291471 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatic Diseases

Interventions

DRUG: T0001，10mg
DRUG: T0001，20mg
DRUG: T0001，35mg
DRUG: T0001，50mg
DRUG: T0001，65mg
DRUG: T0001，75mg

Sponsor

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.